Rakovina Therapeutics Inc (RKV)
TSXV
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Return on Assets (%) | -46.986 | -116.587 | -37.77 | -46.379 |
Return on Equity (%) | -49.546 | -118.54 | -38.343 | -54.021 |
Return on Invested Capital (%) | -37.613 | -35.384 | -25.594 | -29.69 |
Operating Margin (%) | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.051 | 0.042 | 0.014 | -0.012 |
Earnings Per Share | -0.013 | -0.079 | -0.04 | -0.037 |
Cash Per Share | 0.054 | 0.04 | 0.013 | 0.006 |
Working Capital Per Share | 0.051 | 0.042 | 0.014 | 0.007 |
Operating Profit Per Share | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.013 | -0.079 | -0.04 | -0.037 |
EBITDA Per Share | -0.013 | -0.079 | -0.04 | -0.037 |
Free Cash Flow Per Share | -0.013 | -0.085 | -0.048 | -0.045 |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
Shares Outstanding | 15M | 69.81M | 69.83M | 70.08M |
Market Cap | 9.11M |
Price to Earnings Ratio | -5.36 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 32.26 |
Price to Book Ratio | 3.83 |
Dividend Yield | - |
Shares Outstanding | 70.08M |
Average Volume (1 week) | 231.37k |
Average Volume (1 Month) | 329.13k |
52 Week Change | 87.50% |
52 Week High | 0.15 |
52 Week Low | 0.005 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.